跳至主要内容
临床试验/DRKS00020797
DRKS00020797招募中不适用

Addiction recovery of opioid dependent patients treated with injectable subcutaneous depot buprenorphine (BUVIDAL®) - ARIDE

niversitätsklinikum Hamburg-Eppendorf, Klinik für Psychiatrie und Psychotherapie (W37), Zentrum für Interdisziplinäre Suchtforschung (ZIS)0 个研究点目标入组 426 人开始时间: 2020年3月6日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
426

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • (1) Opioid dependence (F11.2) according to ICD-10; (2) Minimum age of 18 years; (3) Ability to follow the study conditions; (4) Signed written informed consent.

排除标准

  • (1) Existing contraindications according to the patient's specialist information to use BUVIDAL® (e.g. hypersensitivity to the active substance, severe respiratory failure, severe liver dysfunction, acute alcoholism or delirium tremen); (2) patient already in substitution treatment with BUVIDAL®; (3) Predictable reasons for early dropout (e.g. detention, planned place of residence and change of doctor)

研究者

发起方
niversitätsklinikum Hamburg-Eppendorf, Klinik für Psychiatrie und Psychotherapie (W37), Zentrum für Interdisziplinäre Suchtforschung (ZIS)

相似试验